Develops oral osteoporosis treatments.
Jun 2026Revenue $0.00/yrExpenses $14.4M/yr
No trendCash runway ≈ 1.0 years from Jun 2026
Figures by year
When will Entera Bio be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $0.00 and expenses $14.4M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $42.0K | $11.6M | −$11.5M |
| Dec 2024 | $181K | $9.77M | −$9.59M |
| Dec 2023 | $0.00 | $8.89M | −$8.89M |
| Dec 2022 | $134K | $13.2M | −$13.0M |
| Dec 2021 | $571K | $12.8M | −$12.2M |
| Dec 2020 | $365K | $11.5M | −$11.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.